ATLAS / Macro Radar / Reporting / LYEL

Lyell Immunopharma, Inc. (LYEL) reporting calendar

Lyell Immunopharma, Inc. files periodic reports with the SEC as LYEL on Nasdaq. Atlas tracks 20 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
26 Jul 2026 – 29 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
6 May 2026
Reports on record
20

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open LYEL market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20266 May 202636 days0001628280-26-031284
10-K31 Dec 202512 Mar 202671 days0001628280-26-017253
10-Q30 Sep 202512 Nov 202543 days0001628280-25-051619
10-Q30 Jun 202512 Aug 202543 days0001806952-25-000008
10-Q31 Mar 202513 May 202543 days0001628280-25-025135
10-K31 Dec 202411 Mar 202570 days0001628280-25-011978
10-Q30 Sep 20247 Nov 202438 days0001628280-24-046285
10-Q30 Jun 20247 Aug 202438 days0001628280-24-035617
10-Q31 Mar 20246 May 202436 days0001628280-24-020467
10-K31 Dec 202328 Feb 202459 days0001628280-24-007592
10-Q30 Sep 20237 Nov 202338 days0001628280-23-037360
10-Q30 Jun 20238 Aug 202339 days0001628280-23-028215
10-Q31 Mar 20234 May 202334 days0001628280-23-015765
10-K31 Dec 202228 Feb 202359 days0001628280-23-005572
10-Q30 Sep 20228 Nov 202239 days0001628280-22-028929
10-Q30 Jun 20224 Aug 202235 days0001628280-22-021109
10-Q31 Mar 202210 May 202240 days0001628280-22-013611
10-K31 Dec 202129 Mar 202288 days0001628280-22-007708
10-Q30 Sep 202112 Nov 202143 days0000950170-21-004270
10-Q30 Jun 202112 Aug 202143 days0000950170-21-001389

Source: SEC EDGAR company submissions for CIK 0001806952. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.